Hyaluxelle®

Medical device

Hyaluxelle® is indicated for adult women to treat the vulvar vestibule in cases of atrophy, dryness, burning or non-infectious itching, or pain of the vaginal introitus during intercourse5.

Hyaluxelle pre-filled syringe box by IBSA - Injectable hyaluronic acid solution (3.2%) with NAHYCO Hybrid Technology

Highlights

Protocol

Two treatment sessions with an interval of 30 days, following the suggested injection technique5

Improvement

Improvement in vaginal symptoms and sexual function in patients with VVA2,3,4

Tolerability

Well tolerated in the genital area2

Quality of life

Positive trend on HRQoL4

Technology

Nahyco®Hybrid technology: stabilized high and low molecular weights HA for a synergistic contribution to tissue regeneration1

Clinical evidence

Improvement in vaginal symptoms of VVA2

Supports the restoration of vaginal tissue structure3

Improvement in sexual function2,4

Acceptable safety profile2,3

Beneficial impact on frequency of sexual intercourse, emotions and relationships2,4

Contact IBSA
Back to the Hyaluxelle® product line

Hyaluxelle® product line

Hyaluxelle® Ovules

Medical device

Hyaluxelle box and blister pack by IBSA - Vaginal ovules for the treatment of vaginal dryness
Discover the details

Hyaluxelle® Intimate cleanser

Cosmetic

Hyaluxelle Intimate Care box by IBSA - Gentle intimate cleanser with pH 4 for daily hygiene
Discover the details
Artistic metaphor of a woman emerging from a marble statue, symbolizing tissue regeneration and the restoration of vitality

Section reserved for healthcare professionals

This section contains information intended for healthcare professionals. By continuing, you confirm that you are a healthcare professional authorized to access this content.

Are you a healthcare professional (HCP)?

No, go back

References

  • 1 / Humzah D, et al. Int J Mol Sci. 2024;25(6):3216.
  • 2 / Garavaglia E, et al. Med Devices (Auckl). 2020;13:399-410.
  • 3 / Garavaglia E, et al. Aesthetic Medicine. 2023;9(1):35-42.
  • 4 / Mohammed GF, et al. Health Sci Rep. 2023;6(3):e870.
  • 5 / HYALUXELLE®. Instructions for Use.